Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
China · Delayed Price · Currency is CNY 8.02
-0.04 (-0.50%)
Sep 4, 2026, 3:00 PM CST
SHA:600867 Revenue
Tonghua Dongbao Pharmaceutical had revenue of 805.18M CNY in the quarter ending June 30, 2026, with 7.96% growth. This brings the company's revenue in the last twelve months to 3.10B, up 16.34% year-over-year. In the year 2025, Tonghua Dongbao Pharmaceutical had annual revenue of 2.95B with 46.66% growth.
Revenue (ttm)
3.10B
Revenue Growth
+16.34%
P/S Ratio
5.06
Revenue / Employee
925.08K
Employees
3,354
Market Cap
15.69B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.95B | 937.63M | 46.66% |
| Dec 31, 2024 | 2.01B | -1.07B | -34.66% |
| Dec 31, 2023 | 3.08B | 296.96M | 10.69% |
| Dec 31, 2022 | 2.78B | -489.44M | -14.98% |
| Dec 31, 2021 | 3.27B | 375.73M | 12.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.